Stocktoria
Fisher & Paykel Healthcare Corporation Limited FPH.NZ
NZ · New Zealand Exchange · XNZE · stock · Healthcare · website
Fisher & Paykel Healthcare Corporation Limited financials (annual, from 10-K)
Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | $2.3B | $1.3B | $1.8B | $1.6B |
| Gross profit | $1.5B | $530.2M | $1.1B | $945.9M |
| R&D expense | $235.5M | $226.9M | $198.2M | $174.3M |
| SG&A expense | $598.2M | $534.4M | $492.8M | $431.9M |
| Operating income | $477.8M | -$371.0M | $254.4M | $240.7M |
| Interest expense | $10.3M | $11.1M | $18.2M | $6.7M |
| Income tax | $163.0M | $126.1M | $103.1M | $77.7M |
| Net income | $468.5M | $377.2M | $132.6M | $250.3M |
| EPS (diluted) | $0.79 | $0.64 | $0.23 | $0.43 |
| Cash & equivalents | $461.1M | $264.5M | $82.0M | $121.0M |
| Inventory | $327.3M | $342.9M | $320.4M | $365.8M |
| Total assets | $2.9B | $2.6B | $2.3B | $2.2B |
| Total liabilities | $738.2M | $660.4M | $522.6M | $451.1M |
| Shareholders' equity | $2.1B | $1.9B | $1.8B | $1.8B |
Growth · year-over-year · Revenue CAGR 13.3%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue growth | +80.3% | -27.2% | +10.7% | — |
| Net income growth | +24.2% | +184.5% | -47.0% | — |
| EPS growth | +24.1% | +182.7% | -47.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · NZ · as of 2026-03-31. Figures in NZD; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.